Alteration in Dissolution Characteristics of Gelatin-Containing Formulations: A Review of the Problem, Test Methods, and Solutions

Published on: 
,
Pharmaceutical Technology, Pharmaceutical Technology-04-02-2002, Volume 26, Issue 4

Eventual change in the dissolution characteristics of some dosage forms, which is ascribed to cross-linking of gelatin, continues to present challenges to drug manufacturers. The authors discuss the causes, mechanisms, and solutions to the problem.

Related Content:

AnalyticsAnalytical Method DevelopmentPharmaceutical Technology-04-02-2002
Newly Opened Innovation Center in New Jersey Gives Avantor Advantage in Solving Life Sciences Challenges
Untethered Data: Unifying and Contextualizing Drug Discovery Data
Abzena Expands Microbiology Laboratory Space